In this video, Paolo Tarantino, MD, PhD, an advanced fellow at Dana-Farber Cancer Institute, discusses the “need and appeal” for oncology education to contextualize “emerging and evolving data in ...
A narrative review examines how generative AI tools such as large language models and vision-language models could assist precision oncology by interpreting genomic data, matching patients to clinical ...
AI-powered digital workflow brings greater consistency, efficiency, and collaboration to bone marrow morphologyCellaVision today announced the launch of the CellaVision® Bone Marrow Aspirate (BMA) ...
Priority review and Project Orbis evaluation advance potential post-neoadjuvant use of trastuzumab deruxtecan for high-risk HER2-positive early breast cancer with residual disease after neoadjuvant ...
Johnson & Johnson’s standout trial results for its Tecvayli and Darzalex Faspro pairing in previously treated relapsed or refractory multiple myeloma have earned the company the third ultra-spe | FDA ...
Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.
Lonial emphasizes that the EXCALIBER-RRMM trial is a test case for a new regulatory framework. The study utilizes dual primary end points to satisfy both accelerated and full approval requirements: ...
The Inflation Reduction Act introduced Medicare drug price negotiations to reduce treatment costs, enhance access, and potentially reshape prescribing patterns in oncology and hematology.
Objective: To explore the risk factors for perianal infections in patients with neutropenia and evaluate the effectiveness of different preventive measures. Methods: A r ...
Edward Luca is an Associate Editor of the Journal of the Australian Library and Information Association (JALIA) and a Director of the Aurora Foundation Ltd. Hamid R. Jamali and Simon Wakeling do not ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The large physician group has a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results